Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2025-11-03 00:00:00 ET · period of report 2025-05-14 · accession 0002064832-25-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-11-03 | 2025-05-14+ | ORGO | NUSSDORF GLENN H | Dir, 10% | P - Purchase | $3.06 | +358.5K | 251.0K | New | +$1.10M |
| MI | 2025-11-03 | 2025-06-09+ | ORGO | NUSSDORF GLENN H | Dir, 10% | S - Sale | $3.55 | -22.8K | 354.3K | -6% | -$80.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-05-15 | P | A | 107,494 | $2.99 | 358,495 | I By Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998 | — | — | (F2) The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.9725 to $3.00, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. |
| 2 | Common | Class A Common Stock | 2025-06-10 | S | D | 18,620 | $3.56 | 335,719 | I By Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998 | — | — | (F4) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.55 to $3.59, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. |
| 3 | Common | Class A Common Stock | 2025-05-14 | P | A | 251,001 | $3.09 | 251,001 | I By Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998 | — | — | (F1) The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.00 to $3.10, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. |
| 4 | Common | Class A Common Stock | 2025-06-09 | S | D | 4,156 | $3.50 | 354,339 | I By Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998 | — | — | (F3) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.505, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. |